CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 1 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $121,157 | – | 20,746 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 4,420,349 | $25,814,838 | 3.96% |
Parkman Healthcare Partners LLC | 1,203,484 | $7,028,347 | 1.87% |
SPHERA FUNDS MANAGEMENT LTD. | 1,002,783 | $5,856,253 | 1.26% |
TANG CAPITAL MANAGEMENT LLC | 1,150,000 | $6,716,000 | 0.98% |
BVF INC/IL | 3,629,000 | $21,193,360 | 0.89% |
Nantahala Capital Management | 1,732,388 | $10,117,146 | 0.66% |
AWM Investment Company, Inc. | 666,661 | $3,893,300 | 0.56% |
INGALLS & SNYDER LLC | 1,295,833 | $7,568 | 0.41% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 200,800 | $1,172,672 | 0.36% |
Kensington Investment Counsel, LLC | 58,599 | $342,218 | 0.27% |